Cardinal Health Q4 revenue up 6%, EPS rises 70%, FY27 EPS guidance raised to $12.40-$12.60
Cardinal Health reported a 6% increase in Q4 revenue to $63.7 billion and a 70% rise in GAAP diluted EPS to $1.70, driven by strong pharmaceutical sales and tariff refunds. Fiscal year 2026 revenue grew 14% to $254.2 billion, with non-GAAP diluted EP...
